Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Avalon Ventures
Biotech
Jnana nets $50M to push newly unveiled PKU program
After years chasing a hard-to-drug group of targets, Jnana is revealing its lead program and a new $50 million round to get it into the clinic.
Amirah Al Idrus
Aug 18, 2021 7:00am
Merck buys Calporta for preclinical neurodegeneration assets
Nov 13, 2019 7:36am
Startup Jnana raises $50M to tackle elusive protein targets
Dec 15, 2017 8:43am
UCSF-based startup nabs $18M Series A for I/O in late-stage cancers
Sep 27, 2016 8:00am
